Inovio Biomedical Corp (INO) reported third quarter net loss attributable to Inovio Biomedical of $2.95 million, compared to net loss attributable to Inovio Biomedical of $2.34 million last year. Loss per share was $0.03, narrower than $0.05 in the prior year quarter.
Total revenue grew to $3.65 million from $455 thousand in the same quarter last year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.